轉(zhuǎn)棒實驗是運動協(xié)調(diào)方面藥物篩選的重要方法。根據(jù) N.W Dunham 和 T.S Miya 1957年的論文。在1960年,Ugo Basile設(shè)計了第一個RotaRod轉(zhuǎn)棒儀。
轉(zhuǎn)棒實驗是運動協(xié)調(diào)方面藥物篩選的重要方法。根據(jù) N.W Dunham 和 T.S Miya 1957年的論文。在1960年,Ugo Basile設(shè)計了第一個RotaRod轉(zhuǎn)棒儀。
數(shù)據(jù)讀?。?/strong> | 液晶顯示 | 數(shù)據(jù)采集: | 52050-07軟件 |
轉(zhuǎn)棒開始: | START (藍色)鍵 | 電源: | universal input 85-264 VAC, 50-60Hz,最大40 W |
轉(zhuǎn)棒停止: | RESET/STOP(紅色)鍵 | 工作溫度: | 10°- 40°C |
設(shè)置速度: | 功能鍵 | 聲級: | < 60 dB |
速度重置: | RESET/STOP (紅色)鍵 | 打?。?/strong> | 7145微型熱敏打印機(需購置) |
轉(zhuǎn)子: | 直徑3cm轉(zhuǎn)鼓 |
物理尺寸 |
|
凈重: |
11.0 Kg |
尺寸: |
46 (w) x 28 (d) x 33 (h) cm |
毛重: |
Kg 16.0 (approx.) |
包裝尺寸: 轉(zhuǎn)子: 走道寬度: 下落高度: |
66 x 50 x63 cm 直徑3cm 5.7cm 16cm |
特征 |
優(yōu)點 |
轉(zhuǎn)速可調(diào)5-80RPM,每次1RPM |
予以小鼠舒適的活動環(huán)境 |
勻速,加速,多次加速模式(新) |
可用于研究運動學(xué)習(xí)機運動功能 |
可使用USB閃存盤 |
無需連接電腦即可儲存數(shù)據(jù) |
新版軟件 |
新款觸摸屏能夠設(shè)置實驗參數(shù)、管理實驗數(shù)據(jù)。 |
方法文獻
§ N.W. Dunham & T.S. Miya: “A Note on a Sinple Apparatus for Detecting Neurological Deficit in Rats & Mice“ J. Am. Pharmaceut. Assoc., Scientific Edit., XLVI: No. 3, 1957
§ B.J. Jones & D.J. Roberts: “The Quantitative Measurement of Motor Inco-ordination in Naive Mice Using an Accelerating Rotarod“ J. Pharm. Pharmac.: 20: 302-304, 1968
使用轉(zhuǎn)棒儀技術(shù)的相關(guān)文獻:
§ B.J. Turner et alia: “Overexpression of Survival Motor Neuron Improves Neuromuscular Function and Motor Neuron Survival in Mutant SOD1 Mice” Neurobiol. Of Aging 35 (4): 906-915,2014
§ M. Milanese et alia: “Knocking Down Metabotropic Glutamate Receptor 1 Improves Survival And Disease Progression in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis” Neurobiology of Disease 64: 48-59, 2014
§ J.E. Lorenz: “Oxidant-Induced Activation of cGMP-Dependent Protein Kinase Iα Mediates Neuropathic Pain After Peripheral Nerve Injury” Antioxidants & Redox Signaling Jan. 2014
§ J.N. Justice et alia: “Battery of Behavioral Tests in Mice that Models Age-Associated Changes in Human Motor Function” Age Oct 2013
§ A.S. Hamlin et alia: “Lesions of the Basal Forebrain Cholinergic System in Mice Disrupt Idiothetic Navigation” PLoS ONE 8(1): e53472, 2013
§ T. Rantam?ki et alia: “The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease” PLoS ONE 8(7): e68722, 2013
§ T. Murakami et alia: “Vascular Endothelial Growth Factor Electro-Gene Therapy Improves Functional Outcome in a Mouse Model of ALS” Immunology, Endocrine & Metabolic Agents: 13 (2): 107-111, 2013
§ R. Günther et alia: “Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)” JoVE J. Vis. Exp. (61), e3936, doi:10.3791/3936, 2012http://www.jove.com/video/3936/clinical-testing-spinal-cord-removal-mouse-model-for-amyotrophic
§ A.J. Grottick et alia: “Studies to investigate the role of 5-HT 2C Receptors on Cocaine- and Food-Maintained Behavior”: J. Pharmacol. Exper. Therap., 2000
§ L.T. Huang et alia: “Pentylenetetrazol-Induced Recurrent Seizures in Rat Pups: Time Course on Spatial Learning and Long…”: Epilepsia, 2002
§ E. Candelario-Jalil et alia: “Wide Therapeutic Time Window for Nimesulide Neuroprotection in a Model of Transient Focal Cerebral Ischemia in the Rat”: Brain Research: 177: 98-108, 2004
§ C.D. Heldermon et alia: “CliTherapeutic Efficacy of Bone Marrow Transplant, Intracranial AAV-mediated Gene Therapy, or Both in the Mouse Model of MPS IIIB” Molecular Therapy 15(5): 873-880, 2010 (rocking)
電話 :
地址 :
電話 :
地址 :
電話 :
地址 :